Topic: Immunotherapy

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.

In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.

We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.